Other equities analysts have also recently issued reports about the company. Cantor Fitzgerald reiterated a buy rating and set a $125.00 price target on shares of Centene in a report on Monday, April 2nd. BMO Capital Markets reiterated a buy rating on shares of Centene in a report on Monday, March 26th. Zacks Investment Research cut Centene from a strong-buy rating to a hold rating in a report on Tuesday, April 10th. Leerink Swann increased their price target on Centene from $120.00 to $130.00 and gave the stock a market perform rating in a report on Monday. Finally, Wells Fargo & Co increased their price target on Centene from $126.00 to $142.00 and gave the stock an outperform rating in a report on Monday. Three research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Centene presently has a consensus rating of Buy and a consensus target price of $124.75.
NYSE CNC opened at $124.61 on Monday. The firm has a market cap of $25.80 billion, a PE ratio of 20.68, a price-to-earnings-growth ratio of 1.21 and a beta of 0.76. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.01 and a quick ratio of 1.01. Centene has a twelve month low of $78.56 and a twelve month high of $126.30.
In related news, Director Robert K. Ditmore sold 8,750 shares of the firm’s stock in a transaction dated Thursday, April 26th. The stock was sold at an average price of $108.15, for a total transaction of $946,312.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Keith H. Williamson sold 2,000 shares of the firm’s stock in a transaction dated Monday, June 11th. The shares were sold at an average price of $120.00, for a total value of $240,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 262,750 shares of company stock valued at $28,461,313 over the last 90 days. 3.00% of the stock is currently owned by company insiders.
Hedge funds have recently bought and sold shares of the business. Focused Wealth Management Inc raised its position in Centene by 900.0% in the 4th quarter. Focused Wealth Management Inc now owns 1,000 shares of the company’s stock valued at $101,000 after purchasing an additional 900 shares in the last quarter. Financial Gravity Companies Inc. acquired a new stake in Centene in the 4th quarter valued at about $112,000. We Are One Seven LLC acquired a new stake in Centene in the 4th quarter valued at about $114,000. Financial Gravity Wealth Inc. acquired a new stake in Centene in the 1st quarter valued at about $114,000. Finally, Tower Research Capital LLC TRC acquired a new stake in Centene in the 4th quarter valued at about $145,000. 76.05% of the stock is currently owned by institutional investors.
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs.
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.